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Purpose: To describe the multimodal imaging (MMI) features of subretinal drusenoid deposits
(SDD) in Indian population.
Methods: Patients diagnosed to have SDD from January 2016 to December 2018 at our tertiary
care center were recruited. The diagnosis of SDDwasmade on the basis of MMI consisting of a
combination of color fundus photography (CFP), optical coherence tomography (OCT), red-free
(RF) imaging, blue autofluorescence (BAF), and near-infra red reflectance (NIR) imaging. The
morphological type and distribution of SDD and the associated retinal lesions were reviewed.
Results: Twenty-three patients with SDD were included. The mean age of the patients was
68.1 ± 12.2 years. SDD were noted in 77.8% of eyes clinically (n = 35/45) and could be detected
in 100% of these eyes with OCT. The morphology of SDD was nodular in 65.7% of eyes (n
= 23/35), reticular in 5.7% (n = 2/35), and mixed pattern in the remaining cases. BAF and
NIR showed hyporeflective nodular lesions often with a target configuration. The location
was commonly in the perifoveal area, mostly involving the superotemporal quadrant (74.3%,
n = 26/35). Associated retinal lesions were type-3 neovascularization or retinal angiomatous
proliferation in 17.1% (n = 6/35), disciform scar in 11.4% (n = 4/35), type-1 neovascularization
in 8.5% (n = 3/35), and geographic atrophy in 5.7% (n = 2/35) of eyes. The mean subfoveal
choroidal thickness was 186.2 ± 57.8 µm.
Conclusion: SDD commonly have a nodular morphology and their identification often requires
confirmations with OCT. Advanced age-related macular degeneration features are frequently
present in eyes with SDD and the fellow eyes.
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INTRODUCTION
Drusen associated with pigmentary changes
are risk factors for late age-related macular
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degeneration (AMD) and related ocular
morbidity.[1–3] Characteristically, drusen are
extracellular deposits between the basal lamina
of retinal pigment epithelium (RPE) and the inner
collagenous layer of the Bruch’s membrane.
Subretinal drusenoid deposits (SDD) also known
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as reticular pseudodrusen (RPD) are a distinct
entity.[4–6] These deposits occur in the subretinal
space above the RPE and are seen predominantly
in the perifoveal area. These may also be
seen in the mid-periphery of the retina. Initial
description of SDDs was using blue filters
in fundus imaging; however, it was difficult
to distinguish them clinically. With the arrival
of modern high-resolution optical coherence
tomography (OCT), these can be picked up with
high sensitivity and specificity.[7, 8] Additional
imaging investigations such as near infra-red
reflectance (NIR) imaging, red-free fundus (RF)
imaging, and short-wave or blue autofluorescence
(BAF) may help increase the detection rates.[7]
SDD have been found to be independent risk
factors for late AMD.[9, 10] A strong association has
been noted between these and type-3 intraretinal
neovascularization,[11, 12] outer retinal atrophy,[13, 14]
and combined outer retinal and RPE atrophy or
geographic atrophy.[9, 10, 15]
Although SDD have been studied in detail in
the past few years, there are no studies describing
SDD in the Indian population. This study aims to
describe the demography, clinical characteristics,
and multimodal imaging (MMI) features of SDD in
the Indian population.
METHODS
This retrospective observational study was
performed at a tertiary eye care center in North
India. The study adheres to the tenets of the
Declarations of Helsinki and to the institutional
guidelines for research. Informed consent was
obtained from all the patients. The participants
were the cases of SDD diagnosed at our center
over a period of three years (2016 to 2018). The
clinical database from the retina lab was reviewed
to identify the patients.
The diagnosis of SDD was made on the basis
of MMI consisting of a combination of either color
fundus photography (CFP), RF imaging, BAF, NIR
imaging, and OCT. The SDD appear as yellowish-
white deposits on CFP, present more superficial
than the conventional drusen. The size is similar
to that of the hard drusen. These are of three
clinical types: nodular or dot type with dot-like
uniformly arranged lesions [Figure 1], reticular type
with broad ribbon-like interlacing deposits [Figure
2], and mixed type with a combination of these
two [Figure 3]. On OCT, these deposits appear as
hyperreflective conical or smooth mounds [Figures
2 and 3], present in the subretinal space, and
may erode into the ellipsoid zone as their stage
progresses. Later, these may undergo resolution
with loss of the outer retinal bands and RPE-
Bruch’s complex. RF or blue-channel imaging
highlights these lesions better as compared to CFP
[Figures 1 and 2]. On BAF, these lesions are often
hypoautofluorescent with a hyperautofluorescent
core sometimes seen in nodular types with
increasing stage. NIR is also useful in picking
up the nodular type of lesions and these appear
as hyporeflective dots as well [Figure 4]. They
may often have a “target” configuration with
a central hyper reflective core and surrounding
hyporeflective annulus.
The MMI imaging was performed using a
swept-source platform (DRI Triton, Topcon
Inc., Oakland, New Jersey, USA). In a subset
of patients, the confocal scanning laser
ophthalmoscope-based imaging system was used
(Spectralis HRA, Heidelberg, Germany). Fundus
fluorescein angiography (FFA) and indocyanine
green angiography (ICGA) were performed
in a subset of patients to identify/document
the coexisting intraretinal/subretinal/sub-
RPE neovascular complex.
The details such as demography, visual acuity,
clinical fundus features, and MMI characteristics
were noted for each case. The key parameters
notedwere themorphological type and distribution
of SDD, and the associated retinal lesions.
Data were recorded on an Excel spreadsheet
and analyzed with STAT 12.1 software. The
parametric variables were represented with
mean and SD, while the nonparametric variables
were represented with median and range. The
visual acuity was converted into the logMAR scale
with counting fingers (CF) vision at 1 feet distance
corresponding to 2.3 units.
RESULTS
Twenty-three patients with SDD were included.
One eye of a patient had phthisis bulbi, therefore,
a total of 45 eyes were finally studied. The mean
age of the patients was 68.1 ± 12.2 years. Of the
23 patients, 19 (78.3%) were >65 years old. The
majority of patients were females (n = 16/23, 69.6%)
with a male-to-female ratio of 0.43:1.
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Figure 1. Multimodal imaging of a case of SDD. (a) Fundus photograph shows multiple dot-like regularly arranged array of whitish
deposits predominantly in the perifoveal area. (b) The lesions are better delineated on blue channel or red-free photograph.
(c) Fundus photograph after a year shows presence of intraretinal hemorrhage and neovascular membrane suggesting the
development of retinal angiomatous proliferation. The number of SDD has decreased. (d) The red-free photograph reveals only
a few SDD in the nasal macula, suggesting the regression of SDD.
SDD were clinically noted in 35 (77.8%) eyes.
The SDD could be detected in all these eyes
with OCT. Bilateral involvement was seen in
52.2% of the cases (n = 12/23). Morphology of
SDD was nodular in 23 eyes (65.7%), reticular
in 2 eyes (5.7%), and mixed pattern in the
remaining 10 eyes (28.6%). The spatial location was
commonly in the perifoveal area, mostly involving
the superotemporal quadrant (74.3%, n = 26/35)
[Table 1] followed by annular distribution (22.5%, n
= 8/35). On studying the spatial location separately
for different morphological types of SDD (see Table
1), the superotemporal quadrant was involved in 19
of 23 eyes (82.6%) and 6 of 10 eyes (60%) with
nodular and mixed types, respectively.
The average logMAR CDVA in eyes with SDD
was 0.53 ± 0.65 (median 0.3, range 0 to 2.3).
CDVA ≥ 20/40 was seen in 20 of 35 eyes (57.1%).
Soft drusen [Figure 5] were present concurrently in
68.6% of eyes with SDD (n = 24/35), out of which
three eyes had drusenoid PED as well. Associated
retinal lesions in eyes with SDD were as follows
(see Table 2): type-3 NV or retinal angiomatous
proliferation (RAP) [Figure 1] in 17.1% (n = 6/35),
disciform scar in 11.4% (n = 4/35), type-1 or sub-RPE
CNV in 8.5% (n = 3/35), and geographic atrophy
(GA) in 5.7% (n = 2/35) of the eyes. The mean
subfoveal choroidal thickness (SFCT) was 186.2 ±
57.8 µm [Figure 6]. The SFCT was <125 µm (cut-off
for age-related choroidal atrophy) in 17.1% (n = 6/35)
and >250 µm in 14.3% of eyes (n = 5/35).
The fellow eyeswithout SDD (n = 10) had average
logMAR CDVA of 1.8 ± 0.76 (median 2.3, range 0.6
to 2.3). Soft drusen were noted in 20% of these
eyes (n = 2/10). Disciform scar, RAP, and type-2
or subretinal CNV were noted in 70% (7/10), 20%
(2/10), and 10% (1/10) of the fellow eyes without SDD,
respectively. The mean SFCT was 178.1 ± 50.4 µm
in these eyes (obtained for nine eyes).
DISCUSSION
Recognition of SDD/RPD in AMD patients is
important because it independently confers
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Figure 2. Multimodal imaging of a case of AMD. (a) Fundus photograph shows multiple soft drusen at the fovea with pigmentary
changes suggestive of non-exudative AMD. Numerous confluent ribbon-like interlacing reticular drusen are seen predominantly in
the perifoveal area in superotemporal quadrant (white arrows). (b) The reticular lesions (white arrows) are better delineated on red-
free imaging. (c) The swept-source OCT through the top white arrow in subfigure “a” shows broad mound-shaped deposits in the
subretinal space (white arrows) deflecting the ellipsoid zone inward suggestive of reticular drusen. The black arrows point to the
sub-RPE deposits suggestive of soft drusen. The subfoveal choroid seems markedly thin with obliteration of the choriocapillaris
layer.
Figure 3. A case of mixed SDD. Fundus photograph shows dot-like SDD (white arrowheads) near the fovea and reticular lesions
(white arrows) in the temporal perifoveal and peri-papillary area. (b) SS-OCT image through the white right arrow in subfigure “a”
shows sharp peaked (white arrowheads) and broad mound-shaped deposits (white arrows) in the subretinal space suggestive of
dot and reticular drusen, respectively.
increased risk (above the usual risk associated
with large soft drusen and pigmentary changes)
of developing the late stage of AMD.[9, 10] In this
study, SDD were associated with late AMD in
42.8% (15/35) of eyes. The risk of late AMD also
increases in the fellow eyes if SDD are present.[16]
The RF or blue channel of CFP shows high
specificity for SDD.[7] The RPE normally filters off
the blue light and therefore the soft drusen, which
are present external to RPE, appear yellow. SDD
lie internal to RPE and are easily visualized in
blue light. Both the nodular and reticular types
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Figure 4.Near infra-red reflectance imaging of SDD. (a) Numerous clearly visible perifoveal SDD appearing as hyporeflective dots.
(b) Numerous dot-like SDDs with a “target” configuration. The central core appears hyperreflective with a hyporeflective annulus.
Figure 5.Multimodal imaging of a case of AMD. (a) Fundus photograph showsmultiple soft drusen at the fovea (white arrowheads).
Numerous dot-like SDD are seen predominantly in the perifoveal area (black arrowheads). (b) The SDD are better delineated than
soft drusen on red-free imaging. (c) SD-OCT image through thewhite arrow in subfigure “a” shows sharp peaked subretinal dot-like
SDD (black arrowheads) disrupting the ellipsoid zone and smooth mounds sub-RPE suggestive of soft drusen (white arrowheads).
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Figure 6. Swept source-based choroidal imaging in eyes with SDD (a–d). While “a” and “d” show near-normal choroidal
morphology, the choroid is severely thinned out in “b” and “c”. The subfoveal choroidal thickness was 166, 74, 115, and 244
in “a”, “b”, “c”, and “d”, respectively.
Table 1. Spatial distribution of subretinal drusenoid deposits or pseudodrusen
Location of SDD∗ Number of eyes (%)
Total (n = 35) Nodular type (n = 23) Reticular type (n = 2) Mixed type (n = 10)
Superotemporal quadrant 26 (74.3) 19 (82.6) 1 (50) 6 (60)
Inferotemporal quadrant 7 (20) 5 (21.7) 0 2 (20)
Superonasal quadrant 6 (17.1) 5 (21.7) 1 (50) 0
Inferonasal quadrant 2 (5.7) 2 (8.7) 0 0
Annular 8 (22.8) 3 (13) 1 (50) 4 (40)
∗SDD, subretinal drusenoid deposits
Table 2. Retinal features in eyes with subretinal drusenoid deposits
Parameters Number of eyes (%)
SDD∗ eyes Fellow eyes (n = 10)
Total (n = 35) Nodular type (n = 23) Reticular type (n = 2) Mixed type (n = 10)
Soft drusen 24 (68.6) 16 (69.6) 1 (50) 7 (70) 2 (20)
Drusenoid PED† 3 (8.6) 1 (4.3) – 2 (20) –
Type 1 NV‡ 3 (8.6) 1 (4.3) – 2 (20) –
Type 2 NV – – – – 1 (10)
Type 3 NV or RAPx 6 ((17.1) 3 (13) 1 (50) 2 (20) 2 (20)
Geographic atrophy 2 (5.7) 2 (8.7) – – –
Disciform scar 4 (11.4) 4 (17.4) – – 7 (70)
∗SDD, subretinal drusenoid deposits; †PED, pigment epithelium detachment; ‡NV, neovascularisation; xRAP, retinal angiomatous
proliferation
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were visible better in blue channel CFP in the
current study. The overlying SDD scatters the
excitation light reaching the RPE and therefore SDD
appear hypoautofluorescent on autofluorescence
imaging.[7]
The patients in our study were mostly elderly
(65+ years) females. Likewise, the population-
based studies have also shown that SDD/PD
are associated with increasing age and female
gender, the odds ratio reported by the Rotterdam
study being 1.2 and 2.1, respectively[17] and that
reported by Blue Mountains eye study being
3.4 and 2.0, respectively.[18] In correlation with
the existing literature,[19] the nodular or dot type
was the most common type in our patients. The
reticular or ribbon type uncommonly occurs in
isolation and only two eyes in our series had this
morphological type. The majority of the SDD were
located in superotemporal quadrant in our study.
SDD start developing in the superior quadrants
and later spread to the inferior hemi-retina.[4]
Previous studies have also shown that SDD occur
preferentially in the perifoveal area corresponding
to an annular area with high rod photoreceptor
density.[20] The impaired dark adaptation in eyes
with SDD supports the hypothesis of origin of SDD
from degenerating rod cells.[21]
Choroid is often severely thinned in eyes with
SDD.[8, 22, 23] In a series of 58 eyes with SDD,
Zweifel et al reported severe choroidal thinning or
choroidal atrophy (<125 µm) in 32 (55.2%) eyes.[8]
Although our study supports the observation of
choroidal thinning in SDD, choroidal atrophy was
noted in only 17.1% of eyes. Binarization studies
have shown decreased choroidal vascularity in
eyes with SDD.[24, 25] Since a few eyes with
SDD also have normal or increased choroidal
thickness (five eyes in this study), it is possible
that the SDD are not directly responsible for
the choroidal thinning. Instead, RPE dysfunction
may be responsible for both SDD formation and
choroidal atrophy.[4]
SDD are dynamic structures. With increasing
stage, they reabsorb and fade out.[8, 14] The fellow
eyes of 10 patients in our series did not have
SDD but had advanced AMD characteristics like
disciform scar and RAP lesions. Perhaps, the SDD
had regressed and were therefore not picked up in
these eyes.
Many studies have shown that late AMD
commonly occurs in eyes with SDD.[9, 10, 13–15, 26] In
a large series of 155 eyes with SDD, Cohen et al
reported features of AMD including soft drusen in
65% (n = 101), CNV (active/ scarred) in 39.3% (n
= 61), and GA in 17.4% (n = 27).[26] In our series
also, the rates of soft drusen, CNV, and GA (68.6%,
37.1%, and 5.7%, respectively) were similar to those
reported by Cohen et al.[26] Not only eyes with
SDD had associated AMD, the fellow eyes also
had choroidal atrophy and CNV in our series. In
addition to the macular neovascular disease and
GA, Spaide et al have also described outer retinal
atrophy as a consequence of SDD.[13]
There are few limitations of the present study
including its retrospective nature. As SDD can be
missed on routine examination, the rate of clinical
SDD may be higher if specifically searched for.
The sample size is relatively small and the study
is based on a tertiary eye center, which could
have led to selection bias. The prevalence and
morphological type of SDD in AMD cases was
not noted, which might improve the understanding
behind the association between SDD and AMD.
To conclude, the patients with SDD in Indian
settings are usually elderly females, with nodular
type being the most common and mostly present
in the perifoveal superior quadrants of the fundus.
Their identification often requires OCT in addition
to the CFP. These are frequently associated with
advanced AMD features in the same eye as well as
in the fellow eye.
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